mated that there were over 2.44 million new cancer cases and 1.23 million deaths in 2008. The incidence rate of cancer varies widely throughout the EU, with European agestandardized rates ranging from 523.9 in France to 265.8 in Cyprus (men) and 432.5 in Denmark to 199.2 in Greece (women) (rates per 100,000) (2).
Introduction
Over 12.6 million new cancer cases and 7.56 million cancer deaths were reported worldwide in 2008, with an estimated global prevalence of 585.8 cases per 100,000 adults (1) . In light of the growing economic and healthcare burden of cancer, it is increasingly important for every nation to assess its own cancer incidence patterns. In the European Union (EU) alone, the European Cancer Observatory esti- (4, 5) . The aim of this study was to investigate the 11-year (1998-2008) incidence rates and trends of cancer in Cyprus and compare them to those of other Mediterranean European countries that reported to IARC in the Cancer Incidence in 5 Continents reports for the period 1997-2002 (6) .
Materials and Methods

Data sources
The Cyprus Cancer Registry (CyCR) is a population-based cancer registry administered by the Cyprus MOH that was established in 1998 with support from MECC and the National Cancer Institute, USA. The CyCR covers the government-controlled southern part of the island of Cyprus, so our analysis does not include patients who are permanent residents of the area that is not under the effective control of the Government of the Republic of Cyprus (Fig. 1 ). Using the classification system established by MECC, the CyCR uses ICD-O-3 to record information on 57 different cancer types, and the CANREG4 software, used for registration, derives the appropriate ICD-10 codes (5, 7) .
We obtained the data for this study from the CyCR in datasets containing a randomized subject identifier (created and kept by the Health Monitoring Unit), year of diagnosis, sex, and age at diagnosis. The best available estimates for the annual age-and sex-specific population sizes were obtained from the annual demographic reports published by the Statistical Service of Cyprus (8) . Figure 2 displays the population pyramid for Cyprus during the 11-year study period.
Statistical analysis
For each of the 26 most common cancer types in Cyprus, we calculated annual sex-specific, crude, and world age-stan-dardized incidence rates. Age-specific incidence rates were calculated for each of 6 pooled age categories (0-29, 30-39, 40-49, 50-59, 60-69 and 70+) using the Doll world population as the standard (9) . Patients with missing age data were excluded from the analysis. The 11-year study period was subdivided into 3 shorter time periods (1998-2002, 2003-2005 and 2006-2008) to facilitate the investigation of incidence trends over time. The choice for this temporal division was due to 1) the period IARC data is available for international comparisons (roughly 1998-2002), 2) the entry of Cyprus in the EU in 2004 in order to capture the larger wave of immigration and emigration that occurred around that time (2003) (2004) (2005) , and 3) the post-EU period (2006) (2007) (2008) .
Based on the derived incidence rates, we calculated sexspecific, age-adjusted annual percent change (APC) and 95% confidence intervals (CIs) of the incidence trends for the 26 cancer types investigated. The sex-specific APCs and their CIs were estimated based on Poisson regression using the year of diagnosis (continuous) and age group (categorical) as covariates and the age-specific count of incident cases as the outcome. Overdispersion was assessed using model diagnostics (such as AIC), and when it existed, negative binomial regression was used as an alternative modeling strategy. When the data was sparse (there was a low number of incident cases for a cancer type) our analysis involved collapsing the youngest age groups and creating ≤40 or ≤50 age groups, as needed. Analysis was performed using the PROC GENMOD procedure in SAS 9.3.
In order to assess how the calculated Cypriot rates compared internationally, we used data from the IARC Cancer Incidence in 5 Continents IX publication for Mediterranean countries that shared regional and lifestyle characteristics with Cyprus (10) . We chose to make comparisons with Italy, Spain, France, Malta and Turkey (selecting the regional registries geographically closest to Cyprus); we will hereafter call these countries the "EUROMED" region. Although Greece shares many characteristics with Cyprus, it was not included in the comparison since it does not have a national cancer registry and consequently has no data available in the IARC publication. We report incidence rates for 1997-2002 for these EUROMED regional registries for all cancer types combined and for the top 10 cancer types in Cyprus.
results
The CyCR recorded a total of 23,806 cases of cancer from 1998-2008, and we excluded 482 cases (2.02%) because of missing age data. These cases represent patients residing in the government-controlled part of Cyprus, for which we have more detailed information on the socioeconomic and environmental factors influencing the population. Cancer incidence in Cyprus could be affected by migration; over the 11-year period of our study a total of about 174,000 longterm immigrants were recorded to have come to Cyprus. However, it should be noted that the majority of these immigrants are of a younger age; 85% were less than 49 years old (11, 12) . The major countries showing migration to Cyprus include Greece, UK and Asia, and after Cyprus joined the EU a wave of immigrants from Eastern European countries was recorded. Tables I and II display the incidence analysis, by sex, for the 3 time blocks of the study period (analysis of these cancer types for the entire 11 years can be found in Tabs. I and II). We analyzed a total of 12,309 male cases (11,970 of which had known age) and 11,497 female cases (11,354 of which had known age). The median age at cancer diagnosis was 68 years for men and 62 years for women. The overall world age-standardized cancer rate among men increased from 195.4 cases per 100,000 during 1998-2002 to 239.0 cases per 100,000 during 2006-2008. For the entire 11-year period, prostate, lung, colorectal and bladder cancer were the most incident cancer types for men. Among women, the overall world age-standardized cancer rate started at 180.6 cases per 100,000 in 1998-2002 and increased to 217.1 cases per 100,000 in 2006-2008. Over the 11-year period, breast, colorectal, uterine and thyroid cancer were the most incident cancer types in women. Breast cancer had the highest incidence of any cancer type for both sexes during all 3 time periods.
The cancer type with the most marked increase in rates over the 3 time blocks was female thyroid cancer, which rose from a world age-standardized rate of 9.9 cases per 100,000 during 1998-2002 to 20.1 in 2006-2008, more than doubling in just 11 years. Breast and prostate cancer showed a sharp increase in incidence rates in the second period (2003) (2004) (2005) , and thyroid cancer showed the biggest increase in the third period (2006) (2007) (2008) . Interestingly, even though Cyprus was the main producer of chrysotile asbestos in Europe, the Table III reports the results of the incidence trend analysis, and Figures 3 and 4 display the trends for the top 5 cancer types in men and women. For both men and women during the period 1998-2008, the annual rate of all types of cancer combined increased significantly at the alpha 0.05 level. Both men and women had similar APCs for all types combined, with the values for men being slightly higher (5.94%) than for women (5.47%). Among men, 10 cancer types displayed significantly increasing trends in incidence rate. The male cancer type with the highest significant APC was prostate cancer (9.2%). Among women, 6 cancer types displayed significantly increasing trends in incidence rate, with multiple myeloma as the highest significant APC (11.94%). Female thyroid cancer had the second highest significant APC, increasing at a rate of more than 10% annually (10.17%). Fig. 3 -Plots of the model-estimated annual age-adjusted incidence rate of the top 5 cancer types for males during the study period.
The plot on the left illustrates the trend in prostate cancer (separated due to its higher incidence rates). The plot on the right depicts the trend in lung, colorectal and bladder cancer and non-Hodgkin lymphoma, which make up the remaining top 5 cancers. Fig. 4 -Plots of the model-estimated annual age-adjusted incidence rate of the top 5 cancer types for females during the study period.
The plot on the left illustrates the trend in breast cancer (separated due to its higher incidence rates). The plot on the right depicts the trend in colorectal, uterine and thyroid cancer and non-Hodgkin lymphoma, which make up the remaining top 5 cancers.
rate of male lung cancer for the entire region. The rates of Cypriot male and female stomach cancer, leukemia and thyroid cancer, as well as prostate, uterine, female lung and male bladder cancers were in line with the rates seen in the rest of the region. For male and female colon cancer, rectal cancer, non-Hodgkin lymphoma, overall cancer, and female bladder cancer, only the Turkish regional registry had rates lower than the Cypriot rates.
Discussion
This study showed that cancer in Cyprus exhibits a number of interesting incidence and trend patterns. First, of the 26 cancer types studied in men and women, there were 16 sex-specific cancer sites which showed significantly increasing trends and none that showed significantly decreasing trends during the study period. Second, a few cancers showed interesting patterns in our analysis. Prostate and breast cancers were the most common cancers in men and women, respectively. The male lung cancer rate was relatively low considering the high smoking rates among men in Cyprus, female thyroid cancer increased significantly in the studied period, and colorectal cancer was the only cancer that was ranked in the top 3 most incident cancers for both men and women for the period 1998-2008. Third, Cypriots have a comparatively lower cancer rate than the populations in the EUROMED region, which share lifestyle similarities with Cyprus.
Through comparisons of the rates of the top 10 cancer sites in men and women in Cyprus with rates in other countries in the EUROMED region, we found that the Cypriot population experiences a relatively low overall cancer rate. In general, Cyprus has either the lowest rate or a rate comparable with the lower end of the EUROMED region countries. It is unclear why cancer rates are lower in Cyprus compared to neighboring countries; however, there are a number of hypotheses that could be investigated. For example, considering the year-round sunny weather and a diet rich in seafood, the population might be exposed to sufficient amounts of vitamin D. Vitamin D has been shown to be a cancer preventive factor, even though there is conflicting literature in the field (13) (14) (15) . Interestingly, Israel, a neighboring country, has higher levels of overall cancer incidence and a documented high prevalence of vitamin D deficiency in the population (16) . According to CI5, the overall age-standardized cancer incidence in Israel for 1998-2002 was 323.4 for men (1.7 times higher than Cypriot men for the same period) and 291.4 for women (1.6 times higher than Cypriot women). Another possible cancer protective factor in Cyprus could be related to the Mediterranean diet, which has been suggested to possibly reduce the risk of breast cancer in Cyprus (17) . When we consider the rate of cancer incidence increase among the top cancer types in Cyprus, the trend of thyroid cancer incidence seems to be most noteworthy. The thyroid cancer incidence rate in Cyprus is higher than in Spain and France, similar to Malta, and lower than in Italy (these countries rank among the highest thyroid cancer rates in the world). There appears to be a higher incidence of thyroid cancer in the Eastern than Western Mediterranean, but this requires further research to confirm. A globally increasing trend of thyroid cancer incidence has been observed, with one possible explanation being overdiagnosis due to more frequent use of needle biopsies. Of course, one cannot exclude the impact of radiation on the thyroid cancer increase. The estimated trends among the top 5 cancer sites in Cyprus suggest that colorectal cancer has surpassed lung cancer to become the second most incident cancer in men. There has been some evidence of a shift in the Cypriot diet away from the traditional Mediterranean diet, and perhaps the increase in colorectal cancer is due to this increase in dietary risk factors (18) .
Breast and prostate cancer rates in Cyprus far outpace all other cancer incidence rates. The observed increases in the rates could possibly reflect the availability of a free mammography screening program for breast cancer (initiated in 2004 and extended nationwide in 2007; it is also interesting to note that Cyprus ranks as the fifth country among 31 countries with the highest number of mammography units per million women) and abundant use of PSA testing, both of which result in increased diagnosis (19) . Interestingly, the largest increase in breast cancer incidence was within the second period (2003) (2004) (2005) , during which the national breast cancer screening program was initiated in 2004. As more time passes, it will be worthwhile to analyze the impact of the breast cancer screening program and PSA testing availability in Cyprus on the breast and prostate cancer incidence and mortality.
There were no cancer sites for which significant decreases in the annual incidence rate during the study period were reported, and significantly increasing trends were reported for 16 sex-specific cancer sites. This suggests that Cyprus' cancer burden will continue to increase in the future and additional policies for cancer management as well as prevention and control should be instituted. Our results are in agreement with the reports of the Cypriot MOH and others (3, 7) .
Environmental exposures play key roles in the development of many cancer types and Cyprus is affected by a unique spectrum of cancer risk factors. Until the late 1980s, Cyprus was the leading producer of chrysotile asbestos in Europe (20) . Air quality needs to be improved; the country exposure levels exceed the allowable limits set by the new EU regulations (21) . In 2002-2003 the primary sources of the air pollution in government-controlled Cyprus were nitrogen oxides (11, 677 tons/year), sulfur dioxide (5,674 tons/year), benzene (maximum daily average 8.4 µg/m 3 in commercial areas), carbon monoxide (35,987 tons/year), and ozone (maximum daily average 102.6 µg/m 3 in mountains) (22) . Another large source of air pollution is particulate matter in the form of dust -local or carried across the Mediterranean from North Africa. The dust carries soot, sulfate particles, metals and inorganic salts, and a number of these particulate pollutants are carcinogenic (23) .
Smoking is another environmental factor associated with the development of many cancer types. In Cyprus, the proportion of daily smokers is high relative to other European nations, especially among men (24) . Based on health surveys conducted in 2003 and 2008, the proportion of daily male smokers has remained around 38%, while the proportion of daily female smokers has increased during the same period from 10.5% to 14.3% (25, 26) . The oldest data available for smoking is from a survey conducted in 1989, which indicated a 43% smoking prevalence in men, suggesting smoking was already common in the 1980s (27). Unfortunately, data on smoking in previous decades is lacking and therefore it is difficult to address the impact of smoking on cancer in Cyprus. It is possible that the tobacco epidemic has not yet affected the cancer incidence in Cyprus, and this will become more evident in the coming decades. However, the high levels of air pollution and the prevalence of smoking since the 1980s at least make the low male lung cancer rate unusual. With regards to other known risk factors, studies have shown that Cypriots are only exposed to average levels of gamma radiation, radon gas, and water pollution (28) (29) (30) (31) (32) (33) . The results of this study reveal that, although Cyprus has a number of known environmental risk factors, the cancer rates remain relatively low when compared to other countries in the EUROMED region.
The MOH proportionately assigns cases with missing age to an age group for rate calculation, while our analysis excluded those cases (2.02% of all cases), leading to a very slight underestimation of the true incidence rate. This analysis identified one source of possible systematic bias in the CyCR. Nearly half of the cases with missing age data (214 of 482, 44.4%) were prostate or bladder cancer patients, and a majority of those cases were attributed to a small group of urologists (see supplemental tables III and IV for details on other cancer types). Over time, the data collection and case identification methods of the registry have evolved. In 2004, the CyCR incorporated data from the national death registry, and in 2007 it began using electronic medical records from the Bank of Cyprus Oncology Center in Nicosia to improve the registry's case-finding capabilities. While the inclusion of death-certificate-only (DCO) cases from the death registry did improve the case coverage, it introduced about 10% of cases annually from 2004 onwards that are currently DCO cases, representing 5.9% of all registry cases. Efforts to follow these patients are ongoing, and as the registry improves it is expected that the proportion of DCO cases will drop. An audit conducted by MECC in 1999 found that the CyCR attained 88% case coverage. The registry has since improved, and based on a 2008 case-finding evaluation, the CyCR is estimated to attain 95% coverage of all cancer cases in government-controlled Cyprus (7) . As the CyCR improves its methods of data collection and physicians improve their diagnostic ability, it is possible that the large increases in the incidence rate of some cancers may be due to improved detection and not true incidence increases for certain cancers (e.g. thyroid cancer).
This publication represents the first in-depth published report on cancer incidence using the data from the CyCR during the years 1998-2008. Our results show that, although there are many environmental risk factors for cancer, the Cypriot population enjoys relatively lower cancer rates compared to other countries in the EUROMED region. Sixteen sex-specific cancer types showed significantly increasing incidence rates, with thyroid cancer in women increasing at a highly significant rate. Future cancer prevention and control research should focus on exploring the epidemiology of lung and thyroid cancers as well as elucidating the effect of breast and prostate screening on changing the cancer incidence and mortality in this population.
